Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase23 Dec 2025Galectin Therapeutics IncGALT:NAQKevin D. FreemanIndependent Director5,5003.55
USD
19.51k USD
Purchase23 Dec 2025Galectin Therapeutics IncGALT:NAQKevin D. FreemanIndependent Director5,5003.55
USD
19.51k USD
Purchase23 Dec 2025Galectin Therapeutics IncGALT:NAQKary EldredIndependent Director7003.73
USD
2.61k USD
Purchase23 Dec 2025Galectin Therapeutics IncGALT:NAQKary EldredIndependent Director7003.73
USD
2.61k USD
Sale22 Dec 2025Guidewire Software IncGWRE:NYQMichael RosenbaumChief Executive Officer and Director1,400200.72
USD
281.01k USD
Purchase22 Dec 2025Octopus Apollo VCTOAP3:LSEChristopher John PowlesNon-Executive Director20,8320.516
GBP
10.75k GBP
Purchase22 Dec 2025Octopus Apollo VCTOAP3:LSEChristopher John PowlesNon-Executive Director9110.487
GBP
444.00 GBP
Purchase22 Dec 2025Octopus Apollo VCTOAP3:LSEMurray SteeleNon-Executive Director,Chairman11,9020.487
GBP
5.80k GBP
Purchase22 Dec 2025Octopus Apollo VCTOAP3:LSEMurray SteeleNon-Executive Director,Chairman4,4030.487
GBP
2.14k GBP
Purchase22 Dec 2025Octopus Apollo VCTOAP3:LSELindsay DodsworthNon-Executive Director5410.487
GBP
263.00 GBP
Purchase22 Dec 2025Autozone IncAZO:NYQMichael A. GeorgeIndependent Director1453,398.13
USD
492.73k USD
Sale22 Dec 2025Franklin Financial Services CorpFRAF:NAQKimberly M. RzompIndependent Director1,50054.07
USD
81.11k USD
Sale22 Dec 2025Artesian Resources CorpARTNA:NSQDian C. TaylorDirector2,22431.97
USD
71.10k USD
Sale22 Dec 2025Vicor CorpVICR:NSQPatrizio VinciarelliChairman of the Board, President and Chief Executive Officer8,100104.98
USD
850.36k USD
Sale22 Dec 2025Vicor CorpVICR:NSQPatrizio VinciarelliChairman of the Board, President and Chief Executive Officer10,000105.24
USD
1.05m USD
28078 total results
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.